APR 26, 2023 11:55 AM PDT

How to Optimize Exome and Hereditary Cancer NGS Workflows

SPONSORED BY: SOPHiA GENETICS

Hear how renowned genomic experts saved time and improved the yield of their hereditary cancer and rare disease NGS workflows using the SOPHiA DDM™ Platform combined with Alamut™ Visual Plus.

You don't want to miss this!
To permanently access this article for free, fill out the short form below.
Access Article
ALREADY ACCESSED THIS ARTICLE? SIGN IN
About the Sponsor
SOPHiA GENETICS is a health tech company democratizing Data-Driven Medicine (DDM) to improve health outcomes and economics worldwide. By unlocking the power of new-generation health data for cancer and rare disease management, the SOPHiA DDM™ platform allows clinical researchers to act with precision and confidence. The company's innovative approach and patented machine learning-based algorithms enable a community of more than 750 institutions to share knowledge, fostering a new era in healthcare.
You May Also Like
Loading Comments...